1 August 2017 in Complementary Therapies in Clinical Practice
14 June 2021 in Mindfulness
25 April 2025 in Frontiers in Psychology
Introduction: Several mindfulness-based interventions (MBIs) have shown efficacy in enhancing interoceptive awareness (IA), the ability to perceive and interpret bodily signals, leading to improved mental and physical wellbeing. However, no study has yet explored the effects of mindfulness practice on IA in individuals training to become MBI teachers. Thus, we investigated the impact of a mindfulness teacher training (MTT) program on emotional distress and IA in individuals training to become mindfulness teachers.Methods: A group of 38 individuals undergoing MTT and a control group of 24 matched individuals were assessed before (T0) and after (T1) the 9 months MTT program. Emotional distress was assessed through the Hospital Anxiety and Depression Scale (HADS) and IA was assessed through the Multidimensional Assessment of Interoceptive Awareness (MAIA).Results: The MTT group showed significantly higher increases in the awareness of mind-body integration in comparison with the control group. Although no significant between-group changes were observed in emotional distress, increases in MAIA self-regulation scores within the MTT group were associated with decreases in HADS depression and total emotional distress scores.Discussion: This study offers further support to the positive impact of mindfulness practice on IA within an MTT program, suggesting that mindfulness training for future MBI teachers further enhances their ability to attend to and to regulate and interpret bodily signals. Future research should investigate the long-term impact of mindfulness training on IA and on mental health in comparison with active comparators.
1 February 2012 in Journal of International Medical Research
OBJECTIVE: This study investigated whether selected D-amino acid oxidase activator (DAOA) gene single nucleotide polymorphisms (SNPs; rs3916966, rs3916967, rs2391191, rs3916968, rs7139958, rs9558571, rs778293) are associated with major depressive disorder (MDD) and bipolar disorder (BD), and whether they can predict clinical outcomes in Korean in-patients treated with antidepressants and mood stabilizers, respectively. METHODS: In total, 145 patients with MDD, 132 patients with BD and 170 psychiatrically healthy controls were genotyped for the DAOA SNPs. Baseline and final clinical assessments included the Montgomery—Asberg Depression Rating Scale and Young Mania Rating Scale for patients with MDD and BD, respectively. RESULTS: There was no association between DAOA SNP genotypes or alleles with diagnosis, clinical improvement, response rates or remission rates for MDD and BD. Haplotype analyses found no association with MDD or BD diagnosis or clinical outcomes. CONCLUSIONS: The findings suggest that the DAOA SNPs investigated may not affect MDD or BD phenotype, clinical symptoms or other clinical factors, and are unlikely to be involved in MDD or BD development and treatment outcomes. Given the study's limitations, further investigation should be carried out.
1 September 2013 in Journal of Affective Disorders